CalciMedica’s $15 Million Series C Financing

Wilson Sonsini Goodrich & Rosati represented CalciMedica in the transaction. On May 22, 2020, CalciMedica Inc. (CalciMedica), a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC)…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now